Humacyte (HUMA) Shareholder's Equity Growth (1y) (2021 - 2026)
Humacyte (HUMA) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-67.75% |
| Dec 31, 2025 |
105.90% |
| Sep 30, 2025 |
92.54% |
| Jun 30, 2025 |
114.32% |
| Mar 31, 2025 |
37.82% |
| Dec 31, 2024 |
-488.82% |
| Sep 30, 2024 |
-272.25% |
| Jun 30, 2024 |
-146.28% |
| Mar 31, 2024 |
-68.06% |
| Dec 31, 2023 |
-88.42% |
| Sep 30, 2023 |
-68.83% |
| Jun 30, 2023 |
-57.04% |
| Mar 31, 2023 |
-21.18% |
| Dec 31, 2022 |
-4.29% |
| Sep 30, 2022 |
56.43% |
| Jun 30, 2022 |
137.46% |
| Mar 31, 2022 |
128.42% |
| Dec 31, 2021 |
134.88% |
| Sep 30, 2021 |
122.62% |
